NTLA Intellia Therapeutics, Inc.
Nasdaq · SEC CIK 1652130 · EDGAR
- Bought, last 12 months
- $1.40M 1 purchases by 1 insiders
- Sold, last 12 months
- $2.17M 16 sales by 7 insiders
- Filings on record
- 160 since 2021-07-06, latest 2026-08-24 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| LEONARD JOHN M | Pres, CEO, Dir | — | $1.44M |
| Cohen Fred E | Dir | $1.40M | — |
| Dulac Edward J III | EVP, CFO | — | $234.2K |
| BASTA JAMES | EVP, GC | — | $112.4K |
| Lebwohl David | EVP, Chief Medical Off | — | $109.6K |
| Dube Michael P | VP, CAO | — | $104.4K |
| Clark Eliana | EVP, Chief Technical Off | — | $96.0K |
| Schultes Birgit C | EVP, CSO | — | $78.9K |
| Bhanji Muna | Dir | — | — |
| Keresty Georgia | Dir | — | — |
Transactions 187
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-08-24 16:05 | 2026-08-20+ | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale | $12.65 | -22.7K | 1.15M | -2% | -$286.8K |
| 2026-07-24 17:26 | 2026-07-22 | NTLA | Dulac Edward J III | EVP, CFO | S - Sale | $11.25 | -8,111 | 148.2K | -5% | -$91.2K | |
| 2026-07-06 17:02 | 2026-07-01 | NTLA | Dube Michael P | VP, CAO | S - Sale | $16.78 | -2,641 | 66.9K | -4% | -$44.3K | |
| T | 2026-07-06 17:01 | 2026-07-02 | NTLA | Dulac Edward J III | EVP, CFO | S - Sale | $18.00 | -4,677 | 156.3K | -3% | -$84.2K |
| D | 2026-06-10 19:08 | 2026-06-09 | NTLA | Verwiel Frank | Dir | A - Grant | $0.00 | +9,200 | 35.1K | +35% | $0 |
| D | 2026-06-10 19:07 | 2026-06-09 | NTLA | Keresty Georgia | Dir | A - Grant | $0.00 | +9,200 | 41.1K | +29% | $0 |
| D | 2026-06-10 19:06 | 2026-06-09 | NTLA | GOODMAN JESSE | Dir | A - Grant | $0.00 | +9,200 | 33.6K | +38% | $0 |
| D | 2026-06-10 19:02 | 2026-06-09 | NTLA | Goff Brian | Dir | A - Grant | $0.00 | +9,200 | 32.6K | +39% | $0 |
| D | 2026-06-10 19:01 | 2026-06-09 | NTLA | Cohen Fred E | Dir | A - Grant | $0.00 | +9,200 | 216.7K | +4% | $0 |
| D | 2026-06-10 19:00 | 2026-06-09 | NTLA | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +9,200 | 143.9K | +7% | $0 |
| D | 2026-06-10 18:57 | 2026-06-09 | NTLA | Bhanji Muna | Dir | A - Grant | $0.00 | +9,200 | 36.4K | +34% | $0 |
| D | 2026-03-03 | 2026-03-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | A - Grant | $0.00 | +9,943 | 131.2K | +8% | $0 |
| 2026-03-03 | 2026-03-01 | NTLA | Dube Michael P | VP, CAO | A - Grant | $0.00 | +17.2K | 69.5K | +33% | $0 | |
| D | 2026-03-03 | 2026-03-01 | NTLA | Clark Eliana | EVP, Chief Technical Off | A - Grant | $0.00 | +7,353 | 94.5K | +8% | $0 |
| D | 2026-03-03 | 2026-03-02 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $13.78 | -607 | 93.9K | -0.6% | -$8,364 |
| D | 2026-03-03 | 2026-03-01 | NTLA | BASTA JAMES | EVP, GC | A - Grant | $0.00 | +46.1K | 158.0K | +41% | $0 |
| D | 2026-03-03 | 2026-03-02 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $13.78 | -1,211 | 156.8K | -0.8% | -$16.7K |
| D | 2026-03-03 | 2026-03-01 | NTLA | Schultes Birgit C | EVP, CSO | A - Grant | $0.00 | +39.2K | 137.7K | +40% | $0 |
| D | 2026-03-03 | 2026-03-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | A - Grant | $0.00 | +156.4K | 1.17M | +15% | $0 |
| D | 2026-03-03 | 2026-03-01 | NTLA | Dulac Edward J III | EVP, CFO | A - Grant | $0.00 | +61.3K | 161.0K | +61% | $0 |
| 2026-01-07 | 2026-01-05 | NTLA | Schultes Birgit C | EVP, CSO | S - Sale | $9.21 | -8,508 | 98.5K | -8% | -$78.4K | |
| 2026-01-07 | 2026-01-05 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $9.21 | -9,515 | 87.1K | -10% | -$87.6K | |
| 2026-01-07 | 2026-01-05 | NTLA | Cohen Fred E | Dir | P - Purchase | $9.35 | +150.0K | 207.5K | +261% | +$1.40M | |
| 2026-01-07 | 2026-01-05 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale | $9.21 | -34.1K | 1.01M | -3% | -$314.5K | |
| 2026-01-07 | 2026-01-05 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $9.21 | -10.4K | 101.5K | -9% | -$95.8K | |
| 2026-01-07 | 2026-01-05 | NTLA | Dulac Edward J III | EVP, CFO | S - Sale | $9.21 | -6,379 | 99.7K | -6% | -$58.8K | |
| 2026-01-07 | 2026-01-05 | NTLA | Dube Michael P | VP, CAO | S - Sale | $9.21 | -2,989 | 52.3K | -5% | -$27.5K | |
| 2026-01-07 | 2026-01-05 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale | $9.21 | -11.9K | 121.2K | -9% | -$109.6K | |
| DMT | 2025-12-12 | 2025-12-11+ | NTLA | LEONARD JOHN M | Pres, CEO, Dir | M - OptEx | $6.83 | +58.5K | 1.05M | +6% | +$399.7K |
| DMT | 2025-12-12 | 2025-12-11 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale+OE | $9.49 | -88.1K | 1.08M | -8% | -$836.4K |
| 2025-10-03 | 2025-10-01 | NTLA | Schultes Birgit C | EVP, CSO | S - Sale | $17.38 | -31 | 105.2K | -0.0% | -$538.78 | |
| 2025-10-03 | 2025-10-01 | NTLA | Dube Michael P | VP, CAO | S - Sale | $17.38 | -1,871 | 55.3K | -3% | -$32.5K | |
| 2025-08-22 | 2025-08-20 | NTLA | CHASE WILLIAM J | Dir | P - Purchase | $10.03 | +100.0K | 134.7K | +288% | +$1.00M | |
| 2025-07-25 | 2025-07-23 | NTLA | Dulac Edward J III | EVP, CFO | S - Sale | $14.02 | -7,462 | 106.1K | -7% | -$104.6K | |
| 2025-07-03 | 2025-07-01 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $9.82 | -1,022 | 95.4K | -1% | -$10.0K | |
| 2025-07-03 | 2025-07-02 | NTLA | Dube Michael P | VP, CAO | S - Sale | $9.95 | -2,503 | 57.1K | -4% | -$24.9K | |
| MT | 2025-07-02 | 2025-06-30+ | NTLA | GOODMAN JESSE | Dir | S - Sale | $9.40 | -3,094 | 25.9K | -11% | -$29.1K |
| D | 2025-06-18 | 2025-06-11 | NTLA | Keresty Georgia | Dir | A - Grant | $0.00 | +8,000 | 31.9K | +33% | $0 |
| D | 2025-06-13 | 2025-06-11 | NTLA | Verwiel Frank | Dir | A - Grant | $0.00 | +8,000 | 25.9K | +45% | $0 |
| D | 2025-06-13 | 2025-06-11 | NTLA | Goff Brian | Dir | A - Grant | $0.00 | +8,000 | 23.4K | +52% | $0 |
| D | 2025-06-13 | 2025-06-11 | NTLA | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +8,000 | 34.7K | +30% | $0 |
| D | 2025-06-13 | 2025-06-11 | NTLA | Bhanji Muna | Dir | A - Grant | $0.00 | +8,000 | 27.2K | +42% | $0 |
| D | 2025-06-13 | 2025-06-11 | NTLA | GOODMAN JESSE | Dir | A - Grant | $0.00 | +8,000 | 27.5K | +41% | $0 |
| D | 2025-06-13 | 2025-06-11 | NTLA | Cohen Fred E | Dir | A - Grant | $0.00 | +8,000 | 57.5K | +16% | $0 |
| T | 2025-05-01 | 2025-04-29 | NTLA | Bhanji Muna | Dir | S - Sale | $8.50 | -265 | 19.2K | -1% | -$2,252 |
| 2025-03-04 | 2025-03-01 | NTLA | Dube Michael P | VP, CAO | A - Grant | $0.00 | +14.0K | 59.6K | +31% | $0 | |
| D | 2025-03-04 | 2025-03-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | A - Grant | $0.00 | +43.2K | 130.9K | +49% | $0 |
| D | 2025-03-04 | 2025-03-01 | NTLA | Schultes Birgit C | EVP, CSO | A - Grant | $0.00 | +37.6K | 105.2K | +56% | $0 |
| D | 2025-03-04 | 2025-03-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | A - Grant | $0.00 | +136.0K | 1.08M | +14% | $0 |
| D | 2025-03-04 | 2025-03-04 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $8.99 | -679 | 95.4K | -0.7% | -$6,104 |
| D | 2025-03-04 | 2025-03-01 | NTLA | Clark Eliana | EVP, Chief Technical Off | A - Grant | $0.00 | +32.0K | 96.0K | +50% | $0 |
| D | 2025-03-04 | 2025-03-01 | NTLA | Dulac Edward J III | EVP, CFO | A - Grant | $0.00 | +47.2K | 113.5K | +71% | $0 |
| D | 2025-03-04 | 2025-03-04 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $8.99 | -2,572 | 111.9K | -2% | -$23.1K |
| D | 2025-03-04 | 2025-03-01 | NTLA | BASTA JAMES | EVP, GC | A - Grant | $0.00 | +40.0K | 114.5K | +54% | $0 |
| T | 2025-01-31 | 2025-01-29 | NTLA | Bhanji Muna | Dir | S - Sale | $9.97 | -265 | 19.5K | -1% | -$2,642 |
| 2025-01-07 | 2025-01-03 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale | $12.18 | -26.8K | 941.1K | -3% | -$326.5K | |
| 2025-01-07 | 2025-01-03 | NTLA | Dube Michael P | VP, CAO | S - Sale | $12.18 | -1,372 | 45.6K | -3% | -$16.7K | |
| 2025-01-07 | 2025-01-03 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale | $12.18 | -9,557 | 87.7K | -10% | -$116.4K | |
| 2025-01-07 | 2025-01-03 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | S - Sale | $12.18 | -8,966 | 77.4K | -10% | -$109.2K | |
| 2025-01-07 | 2025-01-03 | NTLA | Hicks Derek | EVP, Chief Business Off | S - Sale | $12.18 | -6,502 | 59.9K | -10% | -$79.2K | |
| 2025-01-07 | 2025-01-03 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $12.18 | -7,074 | 74.5K | -9% | -$86.2K | |
| M | 2025-01-06 | 2025-01-02+ | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $12.17 | -7,978 | 64.0K | -11% | -$97.1K |
| D | 2025-01-03 | 2025-01-01 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | M - OptEx | — | +3,500 | 86.4K | +4% | — |
| D | 2025-01-03 | 2025-01-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | M - OptEx | — | +7,850 | 967.9K | +0.8% | — |
| D | 2025-01-03 | 2025-01-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | — | +3,189 | 97.2K | +3% | — |
| 2024-10-04 | 2024-10-02 | NTLA | Dube Michael P | VP, CAO | S - Sale | $19.01 | -2,012 | 47.0K | -4% | -$38.2K | |
| D | 2024-07-24 | 2024-07-22 | NTLA | Dulac Edward J III | EVP, CFO | A - Grant | $0.00 | +66.3K | 66.3K | New | $0 |
| 2024-07-03 | 2024-07-01 | NTLA | Dube Michael P | VP, PAO, Interim PFO | A - Grant | $0.00 | +17.8K | 49.0K | +57% | $0 | |
| 2024-07-03 | 2024-07-01 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $22.93 | -405 | 71.5K | -0.6% | -$9,287 | |
| T | 2024-06-20 | 2024-06-17 | NTLA | Verwiel Frank | Dir | S - Sale | $25.00 | -1,505 | 17.9K | -8% | -$37.6K |
| D | 2024-06-17 | 2024-06-13 | NTLA | Goff Brian | Dir | A - Grant | $0.00 | +15.4K | 15.4K | New | $0 |
| D | 2024-06-14 | 2024-06-12 | NTLA | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +7,737 | 26.7K | +41% | $0 |
| D | 2024-06-14 | 2024-06-12 | NTLA | Cohen Fred E | Dir | A - Grant | $0.00 | +7,737 | 49.5K | +19% | $0 |
| D | 2024-06-14 | 2024-06-12 | NTLA | Verwiel Frank | Dir | A - Grant | $0.00 | +7,737 | 19.5K | +66% | $0 |
| D | 2024-06-14 | 2024-06-12 | NTLA | GOODMAN JESSE | Dir | A - Grant | $0.00 | +7,737 | 19.5K | +66% | $0 |
| D | 2024-06-14 | 2024-06-12 | NTLA | Bhanji Muna | Dir | A - Grant | $0.00 | +7,737 | 19.7K | +64% | $0 |
| D | 2024-06-14 | 2024-06-12 | NTLA | Keresty Georgia | Dir | A - Grant | $0.00 | +7,737 | 23.9K | +48% | $0 |
| D | 2024-03-05 | 2024-03-01 | NTLA | BASTA JAMES | EVP, GC | A - Grant | $0.00 | +32.4K | 83.9K | +63% | $0 |
| D | 2024-03-05 | 2024-03-04 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $32.99 | -2,297 | 81.6K | -3% | -$75.8K |
| D | 2024-03-05 | 2024-03-04 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $32.99 | -605 | 71.5K | -0.8% | -$20.0K |
| D | 2024-03-05 | 2024-03-01 | NTLA | Clark Eliana | EVP, Chief Technical Off | A - Grant | $0.00 | +31.2K | 72.1K | +76% | $0 |
| D | 2024-03-05 | 2024-03-01 | NTLA | Hicks Derek | EVP, Chief Business Off | A - Grant | $0.00 | +29.4K | 66.4K | +79% | $0 |
| D | 2024-03-05 | 2024-03-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | A - Grant | $0.00 | +38.7K | 93.1K | +71% | $0 |
| D | 2024-03-05 | 2024-03-01 | NTLA | Goddard Glenn | EVP, CFO | A - Grant | $0.00 | +28.6K | 69.2K | +71% | $0 |
| D | 2024-03-05 | 2024-03-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | A - Grant | $0.00 | +113.6K | 960.1K | +13% | $0 |
| D | 2024-03-05 | 2024-03-01 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | A - Grant | $0.00 | +38.0K | 81.9K | +86% | $0 |
| MT | 2024-01-10 | 2024-01-08 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | S - Sale | $28.87 | -2,275 | 44.6K | -5% | -$65.7K |
| 2024-01-05 | 2024-01-03 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | S - Sale | $29.46 | -5,532 | 46.2K | -11% | -$163.0K | |
| 2024-01-05 | 2024-01-03 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $29.46 | -3,805 | 51.5K | -7% | -$112.1K | |
| 2024-01-05 | 2024-01-03 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale | $29.46 | -19.2K | 846.5K | -2% | -$566.3K | |
| M | 2024-01-05 | 2024-01-03 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $29.50 | -4,608 | 40.8K | -10% | -$136.0K |
| 2024-01-05 | 2024-01-03 | NTLA | Goddard Glenn | EVP, CFO | S - Sale | $29.46 | -5,365 | 40.6K | -12% | -$158.1K | |
| 2024-01-05 | 2024-01-03 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale | $29.46 | -5,843 | 54.4K | -10% | -$172.1K | |
| 2024-01-05 | 2024-01-03 | NTLA | Hicks Derek | EVP, Chief Business Off | S - Sale | $29.46 | -3,877 | 37.0K | -9% | -$114.2K | |
| D | 2024-01-03 | 2024-01-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | M - OptEx | — | +7,848 | 865.7K | +0.9% | — |
| D | 2024-01-03 | 2024-01-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | — | +3,187 | 60.2K | +6% | — |
| D | 2024-01-03 | 2024-01-01 | NTLA | Goddard Glenn | EVP, CFO | M - OptEx | — | +3,062 | 46.0K | +7% | — |
| D | 2024-01-03 | 2024-01-01 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | M - OptEx | — | +3,500 | 51.7K | +7% | — |
| 2023-11-02 | 2023-10-31 | NTLA | Bhanji Muna | Dir | S - Sale | $23.90 | -265 | 12.0K | -2% | -$6,334 | |
| 2023-08-02 | 2023-07-31 | NTLA | Bhanji Muna | Dir | S - Sale | $42.33 | -265 | 12.3K | -2% | -$11.2K |
Purchase Sale Sale after option exercise All abbreviations